Literature DB >> 36201146

Cognitive and Neuropsychiatric Impairment in Dystonia.

Grace A Bailey1, Eva Martin2, Kathryn J Peall3.   

Abstract

PURPOSE OF REVIEW: To review recent literature evaluating psychiatric and cognitive symptoms in dystonia, the two non-motor symptom groups most frequently evaluated in dystonia research and recognised in clinical practice. RECENT
FINDINGS: Recent work has embedded clinical recognition of psychiatric symptoms in dystonia, with depressive and anxiety-related symptoms routinely observed to be the most common. Less explored symptoms, such as self-harm, suicidal ideation, and substance abuse, represent newer areas of investigation, with initial work suggesting higher rates than the background population. Investigation of cognitive function has provided less consistent results, both within individual dystonia subtypes and across the spectrum of dystonias, partly reflecting the heterogeneity in approaches to assessment. However, recent work indicates impairments of higher cognitive function, e.g. social cognition, and disrupted visual and auditory sensory processing. Dystonia demonstrates psychiatric and cognitive symptom heterogeneity, with further work needed to recognise endophenotypes and improve diagnostic accuracy, symptom recognition, and management.
© 2022. The Author(s).

Entities:  

Keywords:  Cognition; Dystonia; Non-motor symptoms; Psychiatric disorders

Year:  2022        PMID: 36201146     DOI: 10.1007/s11910-022-01233-3

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   6.030


  41 in total

1.  Cognitive disturbances in primary blepharospasm.

Authors:  Gabriela Gonzalez Alemán; Gabriel A de Erausquin; Federico Micheli
Journal:  Mov Disord       Date:  2009-10-30       Impact factor: 10.338

Review 2.  Phenomenology and classification of dystonia: a consensus update.

Authors:  Alberto Albanese; Kailash Bhatia; Susan B Bressman; Mahlon R Delong; Stanley Fahn; Victor S C Fung; Mark Hallett; Joseph Jankovic; Hyder A Jinnah; Christine Klein; Anthony E Lang; Jonathan W Mink; Jan K Teller
Journal:  Mov Disord       Date:  2013-05-06       Impact factor: 10.338

3.  Association and Familial Coaggregation of Idiopathic Dystonia With Psychiatric Outcomes.

Authors:  Davide Martino; Gustaf Brander; Per Svenningsson; Henrik Larsson; Lorena Fernández de la Cruz
Journal:  Mov Disord       Date:  2020-09-17       Impact factor: 10.338

Review 4.  A review of psychiatric co-morbidity described in genetic and immune mediated movement disorders.

Authors:  K J Peall; M S Lorentzos; I Heyman; M A J Tijssen; M J Owen; R C Dale; M A Kurian
Journal:  Neurosci Biobehav Rev       Date:  2017-05-18       Impact factor: 8.989

5.  Evaluation of anxiety and depression scales and quality of LIFE in cervical dystonia patients on botulinum toxin therapy and their relatives.

Authors:  Dursun Ceylan; Sevda Erer; Mehmet Zarifoğlu; Nevin Türkeş; Güven Özkaya
Journal:  Neurol Sci       Date:  2019-01-18       Impact factor: 3.307

6.  Relationship of Cognitive Function to Motor Symptoms and Mood Disorders in Patients With Isolated Dystonia.

Authors:  Jennifer A Foley; R Saman Vinke; Patricia Limousin; Lisa Cipolotti
Journal:  Cogn Behav Neurol       Date:  2017-03       Impact factor: 1.600

7.  Sustained attention in cranial dystonia patients treated with botulinum toxin.

Authors:  N Allam; J E Frank; C Pereira; C Tomaz
Journal:  Acta Neurol Scand       Date:  2007-09       Impact factor: 3.209

8.  Executive cognitive deficits in primary dystonia.

Authors:  Richard B Scott; Ralph Gregory; Joanna Wilson; Sarah Banks; Anna Turner; Simon Parkin; Nir Giladi; Carol Joint; Tipu Aziz
Journal:  Mov Disord       Date:  2003-05       Impact factor: 10.338

9.  Cognitive Flexibility in Primary Dystonia.

Authors:  Florian Lange; Caroline Seer; Reinhard Dengler; Dirk Dressler; Bruno Kopp
Journal:  J Int Neuropsychol Soc       Date:  2016-07       Impact factor: 2.892

10.  Adult-onset idiopathic dystonia: A national data-linkage study to determine epidemiological, social deprivation, and mortality characteristics.

Authors:  Grace A Bailey; Anna Rawlings; Fatemeh Torabi; Owen Pickrell; Kathryn J Peall
Journal:  Eur J Neurol       Date:  2021-10-15       Impact factor: 6.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.